Literature DB >> 1741252

Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes.

V Boudný1, O Vrána, F Gaucheron, V Kleinwachter, M Leng, V Brabec.   

Abstract

Modification of DNA and double-stranded deoxyoligonucleotides with antitumour 1,2-diamino-cyclohexanedinitroplatinum(II) (Pt-dach) complexes was investigated with the aid of physico-chemical methods and chemical probes of nucleic acid conformation. The three Pt-dach complexes were used which differed in isomeric forms of the dach nonleaving ligand-Pt(1R,2R-dach), Pt(1S,2S-dach) and Pt(1R,2S-dach) complexes. The latter complex has lower antitumour activity than the other two Pt-dach complexes. Pt(1R,2S-dach) complex exhibits the slowest kinetics of its binding to DNA and of the conversion of monofunctional binding to bifunctional lesions. The anomalously slow electrophoretic mobility of multimers of the platinated and ligated oligomers suggests that bifunctional binding of Pt-dach complexes to a d(GG) site within double-stranded oligonucleotides induces bending of the oligomer. In addition, chemical probing of double-helical deoxyoligonucleotides modified by the Pt-dach complexes at the d(GG) sites reveals that Pt(1R,2S-dach) complex induces more extensive conformational changes in the oligomer than Pt(1R,2R-dach) and Pt(1S,2S-dach) complexes. It is proposed that different effects of the Pt-dach complexes on DNA observed in this work arise mainly from a steric crowding of the axially oriented cyclohexane ring in the DNA adduct of Pt(1R,2S-dach) complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741252      PMCID: PMC310365          DOI: 10.1093/nar/20.2.267

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.

Authors:  J H Burchenal; K Kalaher; T O'Toole; J Chisholm
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II).

Authors:  L Marrot; M Leng
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

3.  Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity.

Authors:  O Vrána; V Brabec; V Kleinwächter
Journal:  Anticancer Drug Des       Date:  1986-04

Review 4.  The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.

Authors:  A Eastman
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

5.  Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes.

Authors:  M M Jennerwein; A Eastman; A Khokhar
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

6.  Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  A Schwartz; L Marrot; M Leng
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

7.  Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.

Authors:  A Eastman
Journal:  Biochemistry       Date:  1986-07-01       Impact factor: 3.162

8.  Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane.

Authors:  J F Vollano; S Al-Baker; J C Dabrowiak; J E Schurig
Journal:  J Med Chem       Date:  1987-04       Impact factor: 7.446

9.  DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  S F Bellon; J H Coleman; S J Lippard
Journal:  Biochemistry       Date:  1991-08-13       Impact factor: 3.162

10.  The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove.

Authors:  J A Rice; D M Crothers; A L Pinto; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  12 in total

1.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

Authors:  J Malina; C Hofr; L Maresca; G Natile; V Brabec
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

3.  DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].

Authors:  V Brabec; O Vrána; O Nováková; V Kleinwächter; F P Intini; M Coluccia; G Natile
Journal:  Nucleic Acids Res       Date:  1996-01-15       Impact factor: 16.971

Review 4.  Oxaliplatin: pharmacokinetics and chronopharmacological aspects.

Authors:  F Lévi; G Metzger; C Massari; G Milano
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

5.  LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.

Authors:  Jie Liu; Xue-Qiong Fu; Wei Zhou; Hong-Gang Yu; Jie-Ping Yu; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

Review 6.  A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer.

Authors:  A A Adjei
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

7.  The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.

Authors:  Eva Roubalová; Veronika Kvardová; Roman Hrstka; Sárka Borilová; Eva Michalová; Lenka Dubská; Petr Müller; Petr Sova; Borivoj Vojtesek
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

8.  Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells.

Authors:  Tereza Muchova; Jitka Pracharova; Pavel Starha; Radana Olivova; Oldrich Vrana; Barbora Benesova; Jana Kasparkova; Zdenek Travnicek; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2013-05-15       Impact factor: 3.358

9.  Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements.

Authors:  Domenico Salerno; Giovanni L Beretta; Giuliano Zanchetta; Simone Brioschi; Matteo Cristofalo; Natalia Missana; Luca Nardo; Valeria Cassina; Alessia Tempestini; Roberto Giovannoni; Maria Grazia Cerrito; Nadia Zaffaroni; Tommaso Bellini; Francesco Mantegazza
Journal:  Biophys J       Date:  2016-05-24       Impact factor: 4.033

10.  {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.

Authors:  Sergey A Abramkin; Ute Jungwirth; Seied M Valiahdi; Claudia Dworak; Ladislav Habala; Kristof Meelich; Walter Berger; Michael A Jakupec; Christian G Hartinger; Alexey A Nazarov; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.